Login / Signup

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes.

Patricia Udaondo MireteAna Hervas-OntiverosAmir RosemblattSalvador Garcia-Delpech
Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)
The results of this study confirmed previous evidence suggesting that DEX is effective for improving BCVA and CMT in patients with DME.
Keyphrases
  • low dose
  • vascular endothelial growth factor
  • high dose
  • soft tissue
  • type diabetes
  • adipose tissue
  • metabolic syndrome
  • age related macular degeneration
  • skeletal muscle